Hendrik Bergsma

Subacute haematotoxicity after PRRT with 177Lu-DOTA-octreotate: prognostic factors, incidence and course

Hendrik Bergsma, Mark Konijnenberg, Boen L.R. Kam et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 173 citations · Full text

Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate

Hendrik Bergsma, Mark Konijnenberg, Wouter A. van der Zwan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 164 citations · Full text

Renal Function, Pathology, Vascular Biology +4

Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Hendrik Bergsma, Kirsten van Lom, Marc H.G.P. Raaijmakers et al. · Journal of Nuclear Medicine · 2017 · 131 citations

Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT

Hendrik Bergsma, Harshad Kulkarni, Dirk Müeller et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 106 citations

First Clinical Experience, Medicine, Gastroenterology +4

Peptide receptor radionuclide therapy (PRRT) for GEP-NETs

Hendrik Bergsma, Esther I. van Vliet, Jaap J.M. Teunissen et al. · Best Practice & Research Clinical Gastroenterology · 2012 · 75 citations

Signal Transduction, Medicine, Neuropeptide Receptor +5